Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;164(2):437-445.
doi: 10.1007/s11060-023-04421-4. Epub 2023 Aug 27.

Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer

Badr Id Said  1 , Hany Soliman  1 , Veronika Moravan  2 , Sten Myrehaug  1 , Chia-Lin Tseng  1 , Jay Detsky  1 , Arjun Sahgal  1 , Ellen Warner  3 , Katarzyna J Jerzak  4   5
Affiliations

Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer

Badr Id Said et al. J Neurooncol. 2023 Sep.

Abstract

Background: We characterized the risk factors and survival of metastatic breast cancer (MBC) patients with brain metastases (BrM) as the first and only site of disease in a large, retrospective cohort.

Methods: MBC patients treated for BrM with radiation at a quaternary institution between 2005 and 2019 were identified. MBC patients with BrM but without concurrent extracranial metastases (ECM) or leptomeningeal disease (LMD) were classified as brain-only. Factors associated with brain-only MBC, brain-specific progression free survival (bsPFS) and overall survival (OS) were investigated.

Results: A total of 691 patients with MBC and BrM were analyzed. Among them, 67 patients (9.7%, n = 67/691) presented with brain-only MBC without concurrent ECM/LMD. Within this subgroup, 40 patients (5.8%, n = 40/691) remained free of any ECM or LMD, while 17 patients (2.5%) developed LMD, and 10 patients (1.4%%) developed ECM with a median follow-up of 8 months (IQR 2-35). Patients with brain-only MBC were more likely to have a single BrM [OR 3.41 (1.62-7.19), p = 0.001] and either HER2+ [OR 3.3 (1.13-9.65), p = 0.03] or TNBC [OR 4.09 (1.42-11.74), p = 0.009] subtypes. Patients who presented with brain-only MBC also had significantly longer OS [HR 0.45, (0.22-0.86), p = 0.008] and a trend toward longer bsPFS [HR 0.67 (0.44-1.03), p = 0.05] compared to those with concurrent ECM/LMD.

Conclusion: Patients with brain-only MBC had a longer bsPFS and OS than those with ECM. Patients with HER2+ and TNBC were more likely to have brain-only disease compared to those with HR+/HER2- MBC.

Keywords: Brain metastases; Brain-only metastases; Breast cancer hormone receptor subtypes; Metastatic breast cancer.

PubMed Disclaimer

References

    1. Kuksis M, Gao Y, Tran W, Hoey C, Kiss A, Komorowski A et al (2021) The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis. Neurooncology 23(6):894–904
    1. Gao Y, Kuksis M, Said Id, Chehade B, Kiss R, Tran AW (2021) Treatment patterns and outcomes of women with symptomatic and asymptomatic breast cancer brain metastases: a single-center retrospective study. Oncologist 26(11):e1951–e1961 - DOI - PubMed - PMC
    1. Wang X, Rosen M, Chehade R, Sahgal A, Das S, Warner E et al (2022) Analysis of rates of brain metastases and association with breast cancer subtypes in Ontario, Canada. JAMA Netw Open 5(8):e2225424–e2225424 - DOI - PubMed - PMC
    1. Kim YJ, Kim JS, Kim IA (2018) Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database. J Cancer Res Clin Oncol 144(9):1803–1816 - DOI - PubMed
    1. Gabos Z, Sinha R, Hanson J, Chauhan N, Hugh J, Mackey JR et al (2006) Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J Clin Oncol 24(36):5658–5663 - DOI - PubMed

Substances

LinkOut - more resources